Cystic Fibrosis Canada's 2022-2023 Impact Report
We are pleased to share our 2022-2023 Impact Report and celebrate the work our community helped us to achieve on behalf of Canadians with cystic fibrosis.
Read MoreNews
All media inquiries can be directed to mediarelations@cysticfibrosis.ca or by calling 1-800-378-2233.
19th Annual Walk To Make Cystic Fibrosis History set to raise funds and awareness of cystic fibrosis at more than 50 events across Canada
Cystic Fibrosis Canada asks participants to go #FurtherForAll Canadians with cystic fibrosis
Read MoreCystic fibrosis researchers come together to tackle priority needs of Canadians living with the disease
Cystic Fibrosis Canada’s Broken Arrow Conference kicks off a new approach to balancing patient needs with impactful, high-quality research
Read MoreFederal Government Announces Progress on Nation-wide Strategy for Rare Disease Drugs
Cystic Fibrosis Canada calls on the provinces and territories to implement strategy and improve access today
Read MoreCYSTIC FIBROSIS CANADA RELEASES CANADIAN CF REGISTRY 2021 ANNUAL DATA REPORT
Report finds nearly 25% of Canadians with CF are taking a CFTR modulator therapy
Read MoreCYSTIC FIBROSIS CANADA ASKS COMMUNITY TO GIVE HOPE FOR ALL THIS HOLIDAY SEASON
Read More
KIN CANADA’S WINNIPEG CLUB MAKES AN EXTRAORDINARY SECOND SIX-FIGURE DONATION TO CYSTIC FIBROSIS CANADA
Service club raises an extraordinary $102,640 to support cystic fibrosis research, care and advocacy
Read MoreStatement from Cystic Fibrosis Canada’s Healthcare Advisory Committee Regarding the 2022 Cold and Flu Season
Read More
ALL PROVINCES AND TERRITORIES NOW FUND TRIKAFTA FOR SIX AND UP
British Columbia becomes final jurisdiction to fund the life changing cystic fibrosis drug
Read MoreNEWFOUNDLAND AND LABRADOR EXPAND ACCESS TO TRIKAFTA, ENSURES LIFE CHANGING DRUG IS ACCESSIBLE TO THOSE WHO NEED IT
Cystic Fibrosis Canada urges British Columbia, the last jurisdiction to fund the drug for children, to fund Trikafta using CADTH’s new guidance
Read More